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Abstract
Background: Streptococcus agalactiae (known as Group B strep, or GBS) is a bacterium
that resides in the gastrointestinal tract and/or vaginal canal and is typically benign, but
during pregnancy and birth it can potentially colonize the neonate, causing early-onset
group B streptococcal disease (EOGBSD) of the neonate. The use of antibiotics has
reduced the morbidity and mortality associated with neonatal infections, but it is not an
entirely effective means of preventing the infections and the development of antibiotic
resistance may render antibiotics ineffective for this purpose. Alternative methods of
preventing GBS colonization are in use by consumers and out-of-hospital birth providers,
but it is unclear whether or not these methods are supported in the literature.
Purpose: To evaluate the literature in support of alternative methods to reduce or prevent
GBS colonization.
Results: Using germ theory as a theoretical framework, twenty-two articles were
identified for review and appraised using the Johns Hopkins Research Evidence
Appraisal Tool. The major findings of the reviewed literature were that chlorhexidine has
not demonstrated consistent benefit in reducing GBS colonization, and both probiotics
and garlic have in vitro effects against GBS, but they lack the testing necessary to support
in vivo use.
Conclusion: There are many alternative methods in practice, but they all suffer from a
lack of literature to guide their use.
Implications for Research and Practice: The findings of this review support the idea
that alternative methods may be a viable alternative to antibiotics, but there is a critical
need for research to definitively support the practice.
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Chapter I: Introduction
Need for Critical Review of a Nurse-Midwifery Problem
Streptococcus agalactiae, most commonly known as “Group B strep” (GBS), is a
gram-positive coccus that can colonize in the vaginal canal. Unless abnormal overgrowth
has taken place, GBS is a normal variant of vaginal flora and is harmless. During
pregnancy however, it is a significant contributor to neonatal GBS infection, which is the
most common cause of neonatal sepsis and meningitis, and the mortality rate with earlyonset GBS disease (EOGBSD) is 2% to 30% (Siewert & Holida, 2010). In the absence of
any other definitive and targeted approach, most birth professionals in the United States
adhere to the universal approach of administering antibiotics to all women who have a
positive GBS culture, which is typically obtained via vaginal and rectal swab at 36 to 37
weeks gestation. Vaginal colonization of GBS has been reported to occur in 10-30% of
women (CDC, 2010) and those women are typically treated with antibiotics in labor to
prevent EOGBSD in the neonate.
The use of antibiotics has become the gold standard of neonatal GBS disease
prevention; however, the supporting evidence is weak. The three primary studies on
which the practice was based are more than 20 years old (Boyer & Gotoff, 1986;
Tuppurainen & Hallman, 1989; Matorras, García-Perea, Madero, & Usandizaga, 1991)
included a total of only 500 women, and the studies have long been criticized for bias and
poor methodology. Antibiotic prophylaxis is the accepted practice in the absence of other
viable alternatives, but there is lack of evidence from well designed and conducted trials
to recommend intrapartum antibiotic prophylaxis (IAP) to reduce neonatal EOGBSD
(Ohlsson & Shah, 2014).
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The risks of antibiotics for the woman include allergic reaction such as hives or
pruritus, anaphylactic reaction, antibiotic drug resistance and perpetuation of drugresistant bacteria and elimination of beneficial vaginal flora potentially causing
opportunistic infections. For the neonate, bacterial flora in the gut can be protective
against pathogens, and alternation of the flora by exposure to antibiotics is a potentially
important risk factor in the development of allergic disease (McKeever, Lewis, Smith, &
Hubbard, 2002). The combined use of ampicillin and gentamicin in early life can have
significant effects on the evolution of the infant gut microbiota, the long-term health
implications of which remain unknown (Fouhy, et al., 2012). For both mother and
neonate, intrapartum antibiotic exposure is associated with higher rates of thrush within
one month of delivery (Dinsmoor, Viloria, Lief, & Elder, 2005).
Some birth professionals, primarily midwives, use alternative methods to prevent
or treat GBS colonization. With the goal of removing the need for antibiotics or
minimizing the risk of transmission of GBS to the neonate, these methods have seen
increased usage in recent years. As demonstrated in Table 1, there are a multitude of
alternative methods that are in use. Many of these methods have not been tested in a
research setting, so the goal of this synthesis is to determine what alternative practices, if
any, are supported in the literature for primary prevention of GBS colonization.
Table 1: Alternative Methods to Prevent/Reduce GBS Colonization
Apple cider vinegar
Bentonite clay
Colloidal silver

11

Diatomaceous earth
Essential oils (Melaleuca alternifolia, cinnamomum verum, syzygium aromaticum)
Fermented foods (kefir, kombucha, sauerkraut, kimchi)
Garlic
Probiotics/yogurt
Water birth

Significance to Nurse-Midwifery
This topic is of high interest to midwives in practice, as neonatal sepsis related to
GBS colonization has serious, and potentially fatal, outcomes in neonates. Approximately
10-30% of pregnant women are colonized with GBS in the vagina or rectum, and in the
absence of any intervention, an estimated 1%-2% of infants born to colonized mothers
develop early-onset GBS infections (CDC, 2010). In the United States mortality rates
were reported to be between 4 and 6%, although it has been suggested that the rate of
neonatal disease is considerably underestimated because the requirement for positive
cultures from blood or cerebrospinal fluid underrepresents the true burden of disease
(Johri, et al., 2006). Importantly, morbidity is high, as approximately 50% of neonates
who survive GBS infection suffer complications, including neurological sequelae,
cortical blindness, deafness, uncontrolled seizures, hydrocephalus, hearing loss, and
speech and language delay (Johri, et al., 2006).
Some early onset infections can occur when the neonate is exposed to GBS during
passage through the birth canal, but most early onset infections are probably caused by
ascending movement of the organism from the maternal genital area through ruptured
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membranes into the amniotic fluid, where the organism multiplies and ultimately
colonizes the respiratory tract of the fetus (Johri, et al., 2011). However intact membranes
do not preclude vertical transmission, as GBS can cross intact amniotic membranes
(CDC, 2010).
The current approach of prophylactic antibiotics has been a valiant although only
moderately effective effort to eliminate neonatal sepsis from GBS, and overuse and
resistance to antibiotics is a public health concern. GBS has built resistance to antibiotics
that were previously considered effective, and some strains of GBS have been found to
be resistant to treatment by all currently used forms of antibiotics (Dabrowska-Szponar &
Galinski, 2001). No new classes of antibiotics have been introduced since 2003, and
despite the advances in antimicrobial and vaccine development, infectious diseases still
remain as the third-leading cause of death in the United States (Conly & Johnston, 2005).
The question of time left until there is no longer a viable antibiotic effective against GBS
makes the prevention of GBS colonization particularly critical. Even more concerning is
the treatment for women who are allergic to penicillin, as up to 29% of GBS strains have
been shown to be resistant to non-penicillin antibiotics (Bland, et al., 2001).
Access to antibiotics is not universal, but in the United States access is a concern
unique to midwives practicing outside of the hospital. Depending on the state legislation,
certified professional or direct entry midwives may not be authorized to administer
antibiotics in the home or birth center setting. This restriction forces women who are
seeking to give birth in a home or birth center setting with a midwife to make a critical
decision regarding GBS prophylaxis. Some women choose not to be tested, some choose
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to transfer to a hospital for antibiotic administration if they are GBS positive, and others
choose to prevent or treat GBS with alternative methods.
Many women who seek midwifery care, irrespective of birth setting, do so in part
because of low rates of intervention, and the willingness of midwives to consider
alternative approaches to typical interventions. Studies identified regarding the use of
alternative solutions to antibiotics for GBS may support the practices of midwives who
are unable to administer antibiotics in their practice, and for midwives whose clients
prefer to avoid the use of antibiotics. Alternatives to antibiotics are currently in use
amongst midwives, and further research may suggest that the reasoning behind some of
these practices are not entirely unfounded and may find that the methods have merit.
Conceptual Model/Theoretical Framework
The theoretical model used in this review is germ theory, which is based on
factors that alter the interactions and effects of microorganisms on human life. Germ
theory was first introduced in the early 1800s as medicine developed, and as a theory has
withstood the test of time. Germ theory is not a specific theory with a single author, but
rather discoveries that culminate in the germ theory have had a long gestation period, and
were a collective process (Snowden, 2010). Since its beginnings as a continued study by
many scientists and physicians, most notably Louis Pasteur, Joseph Lister, and Robert
Koch, it has become a foundational theory for virtually all aspects of human biology. At
the time of Lister’s medical practice, ‘As many as 80% of all operations were followed
by hospital gangrene, and almost one half of all patients died after a major operation’
(Alexander, 1985, as cited in Jessney, 2012). After Pasteur, Lister and others showed the
medical significance of bacteria in the 1860s, great progress was made in identifying new
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kinds of bacteria and demonstrating their roles in a host of diseases, including diphtheria,
tuberculosis, and cholera (Thagard, 1997). Each advancement was then built upon by
subsequent research and scientists, starting with the identification of bacteria, recognition
of specific bacteria as the cause of specific diseases, means of preventing infection, and
methods for immunization. Application of germ theory to GBS in this review is the
identification of methods that reduce the incidence of GBS colonization in the
antepartum, defined as the time during labor and birth.
Statement of Purpose
The most common remedies that are in use by consumers and some out-ofhospital birth providers are garlic, chlorhexidine, and probiotics. The intent of this review
is to determine if there is literature to support the use of these methods as a means of
preventing GBS colonization.
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Chapter II: Methods
Search Strategies Used to Identify Research Studies
The databases that were utilized were Embase, CINAHL, PubMED, and the
Cochrane Database of Systematic Reviews. An initial search of PubMed was conducted
using the keywords “group B strep” OR ‘streptococcus agalactiae” AND probiotics,
which yielded 22 items. A search of CINAHL using the keywords “group B strep” OR
‘streptococcus agalactiae” AND probiotics, which yielded 47 items.
An Embase search was conducted with keywords “Streptococcus agalactiae” or
“group B strep”, along with “prenatal”, “prenatal care”, “pregnancy”, “pregnant women”,
“pregnan*” (to capture both pregnant and pregnancy), “antenatal”, “prevent” or
“prophyl*”, “prevention”, “anti-infection agents”, “vaginal”, “antiseptic”,
“complementary therapies”, “without antibiotics”, “no antibiotics”, “chlorhexidine”,
“probiotic”, “probiotics”, “garlic”, “allium”, or “allicin”. This search yielded seven
results.
A search of the Cochrane Database of Systematic Reviews with keywords “group
b strep” and “prevention” yielded six results.
Criteria for Including or Excluding Research Studies
The inclusion criteria requires articles to have been written in English and
published in the last 10 years. Two earlier published articles and one article written in
Turkish were included after the initial inclusion and exclusion criteria applied due to their
applicability to the research question. In addition, the four individual studies that made up
the Cochrane Review were added, although they were older than the chosen criteria.
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Articles were excluded if they focused on secondary prevention, defined as
treating with antibiotics after GBS colonization testing has been performed and resulted
in a positive culture. Articles regarding the creation, testing, and acceptance of a GBS
vaccination or a rapid result GBS test were also excluded as outside of the scope of this
project. Articles that focused on bacterial vaginosis were excluded unless the article had
findings specific to GBS, as there can be multiple pathogens responsible for bacterial
vaginosis. Also excluded were articles that focused on GBS in animal populations.
Number and Types of Studies Selected After application of the
inclusion/exclusion criteria, 18 articles remained. With the four individual articles from
the Cochrane Review, the total articles came to 22. The articles were categorized using
the criteria from Johns Hopkins (Dearholt & Dang, 2012):
•

Level I experimental studies (n=8)

•

Level II, quasi-experimental studies (n=2)

•

Level III, non-experimental studies (n=10)

•

Level IV, clinical practice guidelines (n=0)

•

Level V, non-research literature reviews and case studies (n=2)

Criteria for Evaluating Research Studies
Article quality was then determined using the Johns Hopkins Research Evidence
Appraisal Tool (Dearholt & Dang, 2012). Level I, level II, and level III articles were
evaluated for their consistency of results, sufficiency of sample size, whether or not
controls were adequate, and the comprehensiveness of the literature reviews. Level IV
articles were evaluated for the documentation of search strategy, consistency of results,
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sufficiency of sample size, evaluation of included studies, strength of conclusions, and
date of publication. Level V articles were evaluated for the clarity of expertise, definitive
conclusions, and consistency and use of scientific evidence in recommendations.
Strengths and weaknesses of the individual articles is discussed in Chapter III.
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Chapter III: Literature and Analysis
Major Findings
Garlic. Garlic was frequently mentioned in midwifery periodicals for GBS
prophylaxis, specifically the intravaginal use of garlic cloves, and garlic is a well-known
and well-accepted natural remedy. But despite the general popularity of garlic, very little
was found about the activity of garlic on GBS in the review of the literature.
Ankri and Mirelman (1999) reviewed the antibacterial activity of allicin, which is
one of the active principles of freshly crushed garlic homogenates. Various garlic
preparations have been shown to exhibit a wide spectrum of antibacterial activity against
Gram-negative and Gram-positive bacteria (Ankri & Mirelman, 1999). Authors described
the substrate alliin and the enzyme alliinase as a protective mechanism against microbial
invaders from surrounding soil, and when the membrane that encloses the enzyme and
substrate and compromised, the result is allicin which is antibacterial. However Ankri
and Mirelman reported that GBS strains were found to be resistant to the action of allicin
(1999). It was thought that the hydrophilic capsular layers of the Streptococcus bacteria
prevent penetration of the allicin compound; however, the article did not articulate the
basis for that conclusion.
Cohain (2009) reported using garlic with eight cases of confirmed symptomatic
vaginal GBS of 6 months to 4 years during, not resolved by course(s) of oral antibiotics.
This article references adjunctive local therapies including chlorhexidine and povidoneiodine, but garlic was chosen for its accessibility and ease of use. The women all
successfully resolved the symptoms by using half a freshly cut clove of garlic inserted
vaginally at night and removed in the morning, for 3-6 weeks followed by maintenance
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doses of once every 2-4 days (Cohain, 2009). The subjects were not pregnant and already
had active infections; however, it was the only article that specifically evaluated the use
of an alternative method to treat GBS being used on human subjects.
Cutler, et al., (2009) evaluated the effectiveness of extracts of allicin in water or a
novel gel formulation, specifically for prevention of GBS colonization. The solution was
a 500mg/L aqueous solution, and a combination of the aqueous solution with a
commercially available gel to make up the gel formulation. The two types of allicin
formulations were used on seventy-six non-duplicate clinical isolates of GBS from
vaginal swabs, and the minimum inhibitory concentrations (MICs) and minimum
bactericidal concentrations (MBCs) were determined using a microtiter plate, liquid
culture system. There was a >6 log reduction in bacterial load in all cases compared with
the growth control and there was no detectable growth (detection limit 100 cfu/mL) after
8 or 24 hours of treatment (Cutler, et al., 2009). While this article does support garlic as
being a potentially effective remedy, it still lacks the in vivo testing needed for
acceptance and there is no clear determination of how long the effects of garlic would last
until re-colonization was possible. The most interesting aspect of this article is the
assertion that the different types of preparations (such as cream vs. gel) can impact its
efficacy.
All three articles offer support to garlic as a potential agent for reducing GBS
colonization. However, it is clear that further research is needed to support and direct the
use of garlic.
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Chlorhexidine. Ohlsson, Shah, and Stade (2014) conducted a Cochrane review
of the use of vaginal chlorhexidine during labor in an effort to prevent early-onset
neonatal GBS infections. The four studies in the review are as follows.
Adriaanse, Kollée, Muytjens, Nijhuis, de Haan, and Eskes (1995) evaluated the
effect of chlorhexidine gel placed intravaginally after active labor had started, and found
a modest reduction in vertical transmission of GBS (p = 0.069). The timing of the
intervention may be a factor to consider in future studies, as this study initiated the
intervention after the woman was in active labor and it has been theorized that vertical
transmission may occur before the onset of labor.
Burman and Christensen (1992) evaluated the effectiveness of vaginal flushing
with chlorhexidine on admission rates to special-care neonatal units, and found a modest
improvement. Compared with placebo, antepartum vaginal chlorhexidine disinfection
reduced the overall admission rate to special-care neonatal units from 2.9% to 2.0% (RR
1.48, 95% CI 1.01-2.16; p =0.04). Additionally, the reduction in admissions after
chlorhexidine prophylaxis vs. placebo was greater among infants born of GBS carrier
mothers (5.4% to 2.8%; RR 1.95, 95% CI 0.94-4.03) than among those whose mothers
were non-carriers (24% to 19%; RR 127, 95% CI 0.81-2.00) (Burman & Christensen,
1992).
Stray-Pedersen, Bergan, Hafstad, Normann, Grogaard, and Vangdal (1998)
further reviewed the topic using vaginal douching with chlorhexidine as the intervention.
They found that when comparing the two douched groups (chlorhexidine or saline), the
infants of the chlorhexidine group had significantly less overall neonatal morbidity of
infectious diseases (combined incidences of septicemia, respiratory problems and
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superficial infections) than those of the saline group (p = <0.05, 95% confidence interval
0.00-0.06) (Stray-Pedersen, et al., 1998).
Hennquin, Tecco, and Vokaer (1995) wrote a letter to the editor of the Acta
Obstetrica et Gynecologica Scandinavica that reviewed the results of a randomized
controlled study that evaluated the use of gloves lubricated with chlorhexidine, and found
no reduction in neonatal colonization with GBS.
Cutland, et al. (2009) studied the effect of intravaginal chlorhexidine washes
during labor and full-body neonatal chlorhexidine washes on neonatal sepsis in South
Africa. There were 289 cases of early-onset sepsis, and there was no significant
difference in rates between the intervention group (34.6 per 1000 births) and control
groups (36.5 per 1000 births).
Goldenberg, McClure, Saleem, Rouse, and Vermund (2006) did a literature
review for all articles related to use of chlorhexidine in the context of pregnancy, vagina,
infant, newborn, and neonatal. They further narrowed the review to include only
chlorhexidine use vaginally during pregnancy or as a treatment of the newborn. The
results were not significant improvements in overall maternal and neonatal outcomes;
however, they identified that there was potential benefit in developing countries due to
the low cost and ease of accessibility.
Probiotics. Rönnqvist, Ström, Forsgren-Rusk, and Håkansson (2005) identified
two strains of Lactobacillus that held promise as a urogenital probiotic, using panty liners
impregnated with freeze-dried Lactobacillus. Rönnqvist, Forsgren-Brusk, and Grahn
Håkansson (2006) reported that higher amounts of lactobacilli in the genital tract was
associated with a lower vaginal pH.
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Açikgöz, Gamberzade, Göçer, and Ceylan (2005) reported inhibitory effects of
strains of Lactobacilli on GBS, specifically Lactobacillus rhamnosus.
Ortiz, Ruiz, Pascual, and Barberis (2014) found that Lactobacillus fermentum and
Lactobacillus rhamnosus may protect the vaginal epithelium through a series of barriers
(self-aggregation, co-aggregation with potential pathogens, and adherence) and
interference (receptor binding interference block) mechanisms. Similarly, Pradhan,
Mohanty, and Mishra (2011) focused on specific strains of lactobacilli that had inhibitory
action against pathogens, including GBS.
Ruiz, et al. (2012) describe a synergistic effect when two Lactobacillus species
are used together, reporting the bacteriocin-like inhibitory substances (BLIS) from two
Lactobacillus species being better than the BLIS of each one alone (p = <0.05) as GBS
growth inhibitors. Zárate and Nader-Macias (2006) also evaluated the inhibitory action of
lactobacilli on adhesion of GBS to vaginal epithelial cells, and found that Streptococcus
agalactiae showed a high degree of inhibition by L. acidophilus CRL 1259 and L.
paracasei CRL 1289. Reid, et al. (2003) found that oral use of lactobacillus strains could
alter vaginal flora, supporting the idea that oral probiotic regimens could potentially be
used to alter vaginal flora.
Ephraim, et al. (2012) evaluated the antagonistic effects of two probiotics on
GBS. Lactobacillus rhamnosus HN001 is a specific strain of Lactobacillus, and Florajen
3 is a commercially available probiotic capsule containing lactobacillus acidophilus,
Bifidobacterium lactis, and Bifidobacterium longum. They specifically evaluated the
antagonistic effects of both probiotics against GBS in co-cultures, attachment of Florajen
3 and L. rhamnosus HN001 to cell monolayers, and inhibition of GBS adherence to Vero
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cells and MDCK cells. This study also evaluated the affinity of probiotics to adhere to
host cells which could exclude GBS through competition for attachment sites on host
cells. The understanding of different strains having different effects on host cells is
compelling and could help with identification of strains with the strongest effects against
GBS.
Hanson, VandeVusse, Duster, Warrack, and Safdar (2014) found that there were
no significant differences (p = .05) in GBS colony counts between probiotic and control
group participants’ vaginal or rectal swabs at any of the three data collection points.
However, the two probiotic group participants who were positive for GBS at final culture
had lower colony counts (2 x 102 CFU) on the quantitative cultures than the two control
group participants (7 x 102 CFU and 2.07 x 107 CFU). In addition, the eight GBS
negative averaged 90% adherence compared with two GBS positive women who
averaged 68%, as well as a significant inverse relationship (p = 0.02) between yogurt
ingestion and GBS colonization at 36 weeks gestation (Hanson, et al., 2014). While these
findings are interesting, the sample size (10 in the probiotic group, 10 in the control
group) was insufficient to demonstrate that probiotics can prevent GBS colonization
although it does demonstrate diet as a potential confounding variable, and adherence to a
probiotic regimen as a factor in potential efficacy of the regimen. This was also the only
study to discuss the timing of initiation of probiotic therapy in pregnancy, as well as the
amount of probiotic required to be ingested for efficacy.
The in vitro studies give credence to the idea that probiotics could potentially
prevent GBS colonization. Lindsay, Brennan, and McAuliffe (2014) demonstrated that a
prenatal probiotic capsule intervention had high acceptability and likelihood of
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compliance amongst pregnant women. However, a randomized controlled trial with a
larger sample size would be required before any definitive determination can be made
regarding the efficacy of prenatal probiotic therapy against GBS. If similar results could
be obtained in vivo, the use of these probiotics in preventing and treating GBS infection
in pregnant women would be highly promising (Ephraim, et al., 2012).
Benzalkonium Chloride. Mosca, Russo, and Miragliotta (2005) evaluated the
antimicrobial activity of benzalkonium chloride, which is used as an antiseptic. A total of
52 strains of GBS isolated from vaginal swabs of pregnant women were used, along with
a solution of powdered benzalkonium chloride reconstituted with distilled water. After 24
hours of incubation at 37C, the MIC value was recorded as the lowest concentration of
benzalkonium chloride that inhibited visible growth when compared with that in the
control growth tube (Mosca, Russo, & Miragliotta, 2005). They investigated antibiotic
susceptibility, and found that for all the strains tested benzalkonium chloride
susceptibility was not related to antibiotic resistance. This was the only mention of
benzalkonium chloride in the literature, but there is potential for further study, preferably
a randomized controlled trial evaluating in vivo effects.
Strengths and Weaknesses of the Research Studies
Benzalkonium chloride and garlic may have potential efficacy in their
antibacterial mechanisms, but there is currently so little research that their use is limited
until larger studies can be done. Probiotics seem to have the most potential of any method
in the literature, however they suffer from a lack of in vivo studies and there are many
variables (e.g., required amount to survive the GI tract) that have not been addressed.
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Chlorhexidine was the only method that had enough data to suggest that it was not
a replacement for antibiotics, as literature showed only modest improvement in rates of
neonatal EOGBSD.
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Matrix of the Literature
Source: Açikgöz, Z., Gamberzade, S., Göçer, S., & Ceylan, P. (2005). Inhibitor effect of vaginal lactobacilli on group B
streptococci. Mikrobiyoloji Bulteni, 39(1), 17-23. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15900833
Location: Turkey
Purpose/Level/Quality
Design
Measurement
Findings/Outcomes
Purpose: To evaluate the
Non-experimental study
51 lactobacilli from vaginal
Ten clinical isolates (20%)
effect of lactobacilli on GBS.
swabs and vaginal tablets
and the drug-purified
used on five GBS (four
Lactobacilli had an inhibitory
Level of Evidence: III
clinical isolates and one
effect on GBS growth. Seven
standard strain) by sandwich of the inhibitory clinical
Quality of Evidence: A
plate technique and deferred
isolates were Lactobacillus
antagonism well technique.
rhamnosus. The inhibitory
isolates had higher acid
production than the noninhibitory ones (p = < 0.05),
and pH-adjustment destroyed
their inhibitory effects
entirely.
Strengths: Identification of specific strains of Lactobacilli with inhibitory action, and identification of pH-adjustment as a
factor effecting efficacy.
Limitations: The study only measures in vitro effects. Further research is needed to determine if the effects have in vivo
applicability.
Implications: The inhibitory effects of Lactobacilli, specifically Lactobacillus rhamnosus, have potential as a safe and costeffective method for preventing GBS colonization.
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Source: Adriaanse, A., Kollée, L., Muytjens, H., Nijhuis, J., de Haan, A., & Eskes, T. (1995). Randomized study of vaginal
chlorhexidine disinfection during labor to prevent vertical transmission of group B streptococci. European Journal of
Obstetrics & Gynecology and Reproductive Biology, 61(2). 135-141. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/7556834
Location: The Netherlands
Purpose/Level/Quality
Design
Measurement
Findings/Outcomes
Purpose: Study the effect of
Randomized controlled trial. A sample of 1020 women
The vertical transmission rate
chlorhexidine disinfection on
were randomly assigned to
of S. agalactiae was lower in
the rate of GBS transmission
three groups – the
the chlorhexidine group, but
to the neonate.
intervention group, the
the difference did not reach
placebo group, and the
significance (two-tailed
Level of Evidence: I
control group who received
Fisher’s exact text, p =
no treatment. Chlorhexidine
0.069).
Quality of Evidence: B
gel (containing chlorhexidine
digluconate 0.3g) was
applied once active labor was
determined, and again 10
hours later if delivery had not
occurred.
Strengths: Three groups – intervention, placebo, and control.
Limitations: The intervention was not initiated until active labor was determined.
Implications: It has a modest effect, but the results are not compelling enough to suggest this become standard practice.
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Source: Ankri, S., & Mirelman, D. (1999). Antimicrobial properties of allicin from garlic. Microbes and Infection / Institut
Pasteur, 1(2), 125-129. doi:S1286-4579(99)80003-3
Location: Israel
Purpose/Level/Quality
Design
Measurement
Findings/Outcomes
Purpose: Review the
Literature review
NA
Allicin in its purest form has
literature to evaluate the
antibacterial, antifungal, and
antimicrobial properties of
antiviral activity.
allicin (garlic) compounds.
Level of Evidence: V
Quality of Evidence: B
Strengths: The article specifically referred to the action of allicin on GBS. There was detailed explanation of how allicin
compounds antibacterial functions.
Limitations: The article did not have any information as to how the review was conducted, and there were statements made
with citing a source.
Implications: GBS is a Gram-negative bacterium, and allicin has antibacterial activity against several strains of Gramnegative bacteria. While this article did state that GBS is resistant to allicin, it bears further sources and research before being
considered definitive.
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Source: Burman, L., Christensen, P., Christensen, K., Fryklund, B., Helgesson, A., Svenningsen, N., & Tulles, K. (1992).
Prevention of excess neonatal morbidity associated with group B streptococci by vaginal chlorhexidine disinfection during
labour. The Swedish Chlorhexidine Study Group. Lancet, 340(8811), 65-69. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/1352011
Location: Sweden
Purpose/Level/Quality
Design
Measurement
Findings/Outcomes
Purpose: To evaluate the
Randomized controlled trial. The analysis included 4483
The reduction in admissions
effect of vaginal
mothers and their full-term
after chlorhexidine
chlorhexidine flushes on rates
infants. Vaginal cultures
prophylaxis vs. placebo was
of admission to special-care
were obtained from 4384
greater among infants born of
neonatal units.
women on arrival in the
GBS carrier mothers (5.4% to
delivery ward. 2238 women
2.8%; RR 1.95, 95% CI 0.94had vaginal flushings with
4.03) than among those
Level of Evidence: I
chlorhexidine, and 2245 with whose mothers were nonplacebo, at least once before
carriers (24% to 19%; RR
Quality of Evidence: A
delivery.
127, 95% CI 0.81-2.00)
(Burman & Christensen,
1992).
Strengths: There was a pre-culture to determine GBS status, and evaluation of differences in admission rates between the
GBS carriers, regardless of whether they were in the intervention or control groups.
Limitations: Admission to the special-care nursery may or may not be for issues related to GBS colonization, and is subject to
provider comfort level. No mention of whether or not mothers were previously cultured for GBS, and if any of the mothers
were treated with antepartum antibiotics.
Implications: Vaginal chlorhexidine offers a modest amount of benefit in preventing admissions to special-care neonatal units.
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Source: Cohain, J. (2009). Long-term symptomatic group B streptococcal vulvovaginitis: Eight cases resolved with freshly cut
garlic. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 146(1), 110-111.
doi:10.1016/j.ejogrb.2009.05.028
Location: Israel
Purpose/Level/Quality
Design
Measurement
Findings/Outcomes
Purpose: To report the results Case reports
Eight patients with confirmed All eight women had
of the use of intravaginal
symptomatic vaginal GBS of resolution of their symptoms.
garlic in the setting of chronic
6 months to 4 years duration,
GBS vulvovaginitis.
not resolved by courses of
oral antibiotics. The women
Level of Evidence: V
used half a freshly cut clove
of garlic inserted vaginally at
Quality of Evidence: B
night and removed in the
morning for 3-6 weeks
followed by maintenance
doses of once every 2-4 days.
Strengths: The only article that had in vivo use of garlic on vaginal GBS colonization.
Limitations: The regimen was not detailed regarding the specifics of the regimen for treatment or maintenance. It was unclear
if the patients were pre-cultured to establish that it was GBS.
Implications: Sustained use of intravaginal garlic could be explored as a potential method of reducing GBS colonization.
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Source: Cutland, C. L., Madhi, S. A., Zell, E. R., Kuwanda, L., Laque, M., Groome, M., . . . PoPS Trial Team. (2009).
Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South
Africa: A randomised, controlled trial. Lancet, 374(9705), 1909-1916. doi:10.1016/S0140-6736(09)61339-8
Location: South Africa
Purpose/Level/Quality
Design
Measurement
Findings/Outcomes
Purpose: To determine if
Randomized controlled trial
8011 women (aged 12-51
Rates of neonatal sepsis did
chlorhexidine applied
years) were randomly
not differ between the groups
intravaginally in labor, or
assigned in a 1:1 ratio to
(chlorhexidine 141 [3%] of
neonatal washes at birth
chlorhexidine vaginal wipes
4072 vs control 148 [4%] of
reduce neonatal sepsis.
or external genitalia water
4057; p = 0.6518).
wipes during active labor,
and their 8129 newborn
Level of Evidence: I
289 cases of early-onset
babies were assigned to full
sepsis occurred, with no
body (intervention group) or difference in rates in the
Quality of Evidence: A
foot (control group) washes
chlorhexidine (34.6 per 1000
with chlorhexidine at birth.
births) and control groups
In a subset of mothers
(36.5 per 1000 births).
(n=5144) maternal lower
vaginal swabs and neonatal
skin swabs were obtained
after delivery to determine
colonization with GBS.
Strengths: Large, randomized sample. Done in developing nation.
Limitations: Lack of screening for GBS colonization prior to labor, and the midwives knew who received the intervention and
who did not. Some mothers received antibiotics per protocol, usually due to meconium-stained amniotic fluid.
Implications: Because screening mothers for GBS colonization is not routine, its unclear whether or not chlorhexidine had an
affect on existing GBS colonization. However the study does demonstrate that intravaginal and neonatal application of
chlorhexidine does not affect neonatal sepsis rates.
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Source: Cutler, R. R., Odent, M., Hajj-Ahmad, H., Maharjan, S., Bennett, N. J., Josling, P. D., . . . Dall'Antonia, M. (2009). In
vitro activity of an aqueous allicin extract and a novel allicin topical gel formulation against Lancefield group B streptococci.
Journal of Antimicrobial Chemotherapy, 63(1), 151-154. doi:10.1093/jac/dkn457
Location: United Kingdom
Purpose/Level/Quality
Design
Measurement
Findings/Outcomes
Purpose: To investigate the in Non-experimental study
Seventy-six non-duplicate
By 8 hours there was a >6 log
vitro activity of a novel allicin
clinical isolates of GBS, from reduction in bacterial load in
extract in aqueous and gel
vaginal swabs were streaked all cases compared with the
formulation against 76 clinical
on blood agar plates and
growth control and there was
isolates of Lancefield GBS.
incubated overnight. A
no detectable growth
5000mg/L solution of novel
(detection limit 100 cfu/mL)
Level of Evidence: III
stabilized AEAllicin, and an
after 8 or 24 hours of
allicin gel mixture was
treatment.
Quality of Evidence: A
created by mixing the
solution with a commercially A purified allicin extract was
available gel.
active against all GBS strains
Growth in the presence of a
tested, with MICs ranging
range of concentrations of
between 35 and 95 mg/L.
AEAllicin between 2500 and
2.5 mg/L and growth in IsoSensitest broth containing no
antimicrobial agent (negative
control) were assessed by
spectroscopy.
Strengths: This is the first study to demonstrate differences in types of preparation, and supports gel formulations as a viable
method for using allicin extract.
Limitations: The study was done in vitro and may not have the same applicability in vivo without further research being
performed.
Implications: Allicin extract is active against GBS, and different types of preparations (cream, gel) can impact its efficacy.
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Source: Ephraim E., Schultz R. D., Duster M., Warrack S., Spiegel C.A., & Safdar N. (2012). In-vitro evaluation of the
antagonistic effects of the probiotics Lactobacillus rhamnosus HN001 and Florajen 3 against Group B Streptococci.
International Journal of Probiotics and Prebiotics, 7(3/4), 113-120. Retrieved from
http://connection.ebscohost.com/c/articles/85948295/in-vitro-evaluation-antagonistic-effects-probiotics-lactobacillusrhamnosus-hn001-florajen-3-against-group-b-streptococci
Location: United States
Purpose/Level/Quality
Design
Measurement
Findings/Outcomes
Purpose: To evaluate the
Non-experimental.
The probiotics (L. rhamnosus When co-cultured, L.
effects of two probiotics
HN001 and Florajen 3) and
rhamnosus HN001 inhibited
(Lactobacillus rhamnosus
all the GBS isolates were
the growth of GBS 0191 and
HN001 and Florajen 3)
grown in MRS and Columbia 0192 and decreased that of
against GBS.
broth, respectively, overnight GBS 0193 significantly (p =
and serially diluted in
<0.0001). Florajen 3 inhibited
Level of Evidence: III
Columbia broth to achieve
the growth of GBS 0191 and
the required colony forming
ATCC 12386 and decreased
Quality of Evidence: A
units per ml (CFU/ml). Three that of GBS 0192 by 5 logs.
ml of each GBS isolate was
Both probiotics could attach
co-cultured with 3ml of each well to MDCK and Vero cells
probiotic, and co-cultures
and both protected Vero cells
were grown in Columbia
from GBS 0193 adhesion.
broth which should not favor Both probiotics decreased the
the growth of one organism
number of adherent GBS
or another. The number of
0192 significantly (p =
GBS at 0 hours, 24 hours and <0.05).
48 hours was determined by
plate dilution method on
SBA plates.
Strengths: Multiple features that make probiotic strains more effective were identified.
Limitations: In vitro study may not be applicable to in vivo use.
Implications: This study demonstrated that both L. rhamnosus HN001 and Florajen 3 have potential efficacy in reducing GBS
colonization.
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Source: Goldenberg, R. L., McClure, E. M., Saleem, S., Rouse, D., & Vermund, S. (2006). Use of vaginally administered
chlorhexidine during labor to improve pregnancy outcomes. Obstetrics and Gynecology, 107(5), 1139-1146. doi:107/5/1139
Location: United States
Purpose/Level/Quality
Design
Measurement
Findings/Outcomes
Purpose: To analyze the
Systematic review
NA
While the studies from
literature to determine the
developed countries did not
efficacy of vaginal and
show a significant
neonatal washes in reducing
improvement in maternal and
GBS infections.
neonatal outcomes, there were
improvements of those
Level of Evidence: III
outcomes in developing
countries.
Quality of Evidence: B
Strengths: The studies were split between developed and developing countries.
Limitations: The two largest studies in developing countries were not randomized or blinded.
Implications: Chlorhexidine may offer a low cost, low risk method of improving maternal and neonatal outcomes.
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Source: Hanson, L., VandeVusse, L., Duster, M., Warrack, S., & Safdar, N. (2014). Feasibility of oral prenatal probiotics
against maternal group B streptococcus vaginal and rectal colonization. Journal of Obstetric, Gynecologic, & Neonatal
Nursing, 43(3), 294-304. doi:10.1111/1552-6909.12308
Location: United States
Purpose/Level/Quality
Design
Measurement
Findings/Outcomes
Purpose: To evaluate the
Quasi-experimental study.
A convenience sample of 20 No adverse effects were noted
effects of probiotic use on
healthy women at 28 weeks
in the probiotic group. Two
GBS colonization in pregnant
(+/- 2 weeks) gestation was
women in each group had
women.
recruited from a midwifery
positive GBS colonization at
clinic in a large Midwestern
36 weeks, however those
Level of Evidence: II
city. Ten women received an women averaged 68%
oral probiotic to be taken
adherence to the probiotic
Quality of Evidence: C
once daily, and ten women
regimen compared to the 8
served as the control group.
who were negative (90%)
All women completed a
based on returned pill counts.
questionnaire about dietary
Of note, women who
intake, vaginal cleansing
consumed yogurt were
practices, and sexual activity. significantly more likely to be
All participants had wet
GBS negative (p = 0.02).
mount and vaginal and rectal
cultures at 28, 32, and 36
weeks gestation (+/- 2
weeks).
Strengths: Compliance with the regimen was evaluated and addressed.
Limitations: Very small sample size. Researchers, midwives, and participants were aware of group assignment. The control
group participants did not receive a placebo.
Implications: This could potentially have clinical applicability but needs to be studied further, preferably with a randomized
controlled trial.
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Source: Hennquin, Y., Tecco, L., & Vokaer, A. (1995). Use of chlorhexidine during labor: How effective against neonatal
group B streptococci colonization? Acta Obstetricia et Gynecologica Scandinavica, 74(2), 168.
doi:10.3109/00016349509008931
Location: Belgium
Purpose/Level/Quality
Design
Measurement
Findings/Outcomes
Purpose: To evaluate the use Randomized controlled trial. 59 pregnant women
11 newborns out of 28 (39%)
of chlorhexidine lubricated
antenatally screened as GBS were colonized in the treated
gloves on the rates of
carriers were prospectively
groups versus 13 out of 31
colonization on the rates of
and randomly allocated in
(42%) in the control group (x2
= 0.003).
neonatal GBS colonization.
two groups at the onset of
labor: vaginal examinations
of the treated group with
Level of Evidence: I
systematically performed
with gloves lubricated with 5
Quality of Evidence: B
ml chlorhexidine digluconate
1% cream; the control group
was examined with uncoated
gloves. Swabs for
microbiological examination
were sampled on different
cutaneous areas of the
newborn at delivery.
Strengths: The premise of lubrication rather than vaginal washings has increased comfort level for mother.
Limitations: Small study group. Letter to the editor, this was not publication of the study.
Implications: Chlorhexidine lubricant is not effective in reducing neonatal GBS colonization.
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Source: Lindsay, K. L., Brennan, L., & McAuliffe, F. M. (2014). Acceptability of and compliance with a probiotic capsule
intervention in pregnancy. International Journal of Gynaecology and Obstetrics: The Official Organ of the International
Federation of Gynaecology and Obstetrics, 125(3), 279-280. doi:10.1016/j.ijgo.2014.01.004
Location: Ireland
Purpose/Level/Quality
Design
Measurement
Findings/Outcomes
Purpose: To evaluate the
Randomized controlled trial. A total of 140 obese pregnant Completed questionnaires
acceptability of and
women completed a
were returned by 121 women
compliance with a probiotic
randomized controlled trial
(57 probiotic, 64 placebo).
regimen during pregnancy.
of a daily probiotic or
Acceptability of and
placebo capsule for 4 weeks
compliance with the
Level of Evidence: I
between 24 and 28 weeks of intervention was high: 97% of
pregnancy. A questionnaire
women reported a willingness
Quality of Evidence: B
evaluated the willingness to
to take a probiotic in a future
consider taking a probiotic in pregnancy, over 80% reported
a future pregnancy, ease of
missing no more than 2
use, and level of
capsules. Only 2 participants
convenience.
did not complete the study.
Non-responders to the
questionnaire did not differ
from responders in terms of
capsule compliance (58%
responders vs 63% nonresponders missed 1 or more
capsules; p = 0.317) or
baseline characteristics (age,
ethnicity, parity, education
level).
Strengths: The study being randomized and controlled is a strength, as well as the sample size.
Limitations: The sample size may not be sufficient to make the results generalizable.
Implications: If probiotic regimens are supported in the literature as beneficial, this study supports women being receptive to
and compliant with a probiotic regimen.
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Source: Mosca, A., Russo, F., & Miragliotta, G. (2006). In vitro antimicrobial activity of benzalkonium chloride against
clinical isolates of streptococcus agalactiae. Journal of Antimicrobial Chemotherapy, 57(3), 566-568. doi:10.1093/jac/dki474
Location: Italy
Purpose/Level/Quality
Design
Measurement
Findings/Outcomes
Purpose: To evaluate the
Non-experimental study
The MIC or the MBC was
When the capacity of
inhibitory effect of
determined by broth
benzalkonium chloride to
benzalkonium chloride against
macrodilution. After 24 hours interfere with GBS growth
GBS.
was evaluated, all the isolates
of incubation at 37°C, the
tested were inhibited at MIC
MIC value was recorded as
Level of Evidence: III
values ranging from 0.39 and
the lowest concentration of
6.25 ml/L. The MIC90 (that
benzalkonium chloride that
Quality of Evidence: B
inhibited 90% of the strains)
inhibited visible growth
was 3.12 mg/L. The MBC
when compared with that in
values ranged between 0.78
the control growth tube.
After 24 hours of incubation and 12.50 mg/L and were
similar or slightly higher than
at 37°C in a candle jar, the
CFU were counted and MBC the MIC values. Neither
prolonged incubation (up to
was defined as the lowest
48 hours) nor the use of
concentration of
different culture media
benzalkonium chloride
interfered with the
resulting in the death of
benzalkonium chloride
99.9% or more of the initial
antibacterial activity.
inoculum.
Strengths: Study was done on benzalkonium chloride and several antibiotics.
Limitations: In vitro
Implications: Benzalkonium chloride could be considered as a potential method for reducing GBS colonization
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Source: Ohlsson, A., Shah, V., & Stade, B. (2014). Vaginal chlorhexidine during labour to prevent early-onset neonatal group
B streptococcal infection. Cochrane Database of Systematic Reviews, (12). Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/25504106
Location: Canada
Purpose/Level/Quality
Design
Measurement
Findings/Outcomes
Purpose: Determine the
Systematic review with
Randomized and quasiThere was no statistically
effectiveness of chlorhexidine meta-analysis
randomized trials comparing significant difference in earlyduring labor in women who
vaginal disinfection with
onset GBS disease
are colonized with GBS for
chlorhexidine (vaginal wash
preventing neonatal GBS
or gel/cream) versus placebo,
infection.
or no treatment were
retrieved for review The
authors evaluated for risk of
Level of Evidence: II
bias, measurement of
treatment effect, unit of
Quality of Evidence: B
analysis, missing data, and
reporting biases.
Strengths: Reviewed only randomized controlled trials.
Limitations: Quality of the trials varied as did the risk of bias and quality of evidence.
Implications: Does not support the wide use of chlorhexidine to prevent GBS transmission.
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Source: Ortiz, L., Ruiz, F., Pascual, L., & Barberis, L. (2014). Effect of two probiotic strains of Lactobacillus on in vitro
adherence of Listeria monocytogenes, Streptococcus agalactiae, and Staphylococcus aureus to vaginal epithelial cells. Current
Microbiology, 68(6), 679-684. Retrieved from
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed12&AN=2014259859
Location: Argentina
Purpose/Level/Quality
Design
Measurement
Findings/Outcomes
Purpose: To evaluate the
Non-experimental study
Exclusion assay: VEC and
The lactobacilli showed a
effect of two Lactobacilli
lactobacilli were mixed in a
great capacity of adherence
strains and adherence of GBS
1:1 ratio and incubated with with a mean of 83.5 +/- 26.67
on vaginal epithelial cells
agitation at 37°C for 1 hour. L. fermentum cells and 56.2
(VECs) by exclusion,
Pathogens were added later, +/- 20.87 L. rhamnosus cells
competition, and displacement.
the resulting suspension was per VEC. In competition
assays, the reduction of S.
incubated.
aureus and GBS adherence
Level of Evidence: III
Competition assay: VEC,
observed ranged between 91.2
lactobacilli, and pathogenic
and 94.3 (p = <0.05). L.
Quality of Evidence: A
bacteria were incubated
together with orbital shaking fermentum showed the highest
capacity of adherence (p =
for 60 min.
<0.05). In displacement
Displacement assay: equal
assays, L. fermentum and L.
volumes of pathogenic
rhamnosus were able to
bacterial suspensions and
vaginal cells were mixed and reduce the adherence of S.
aureus, GBS, and L.
incubated at 37°C with
monocytogenes in a
orbital shaking for 60 min.
significant level in this assay
Then a suspension of
(p = <0.01).
lactobacilli was added to
determine if lactobacilli
displace adhered pathogens.
Strengths: The GBS strains were obtained from pregnant patients.
Limitations: In vitro study that may not have the same applicability in vivo.
Implications: These strains of lactobacillus have potential as a method to reduce colonization of GBS.
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Source: Pradhan, P., Mohanty, R., & Mishra, A. (2011). Selection of probiotic lactobacillus species to eradicate resistant
urogenital pathogens in pregnant women. International Journal of Probiotics and Prebiotics, 6(1), 13-20. Retrieved from
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed11&AN=2013649332
Location: India
Purpose/Level/Quality
Design
Measurement
Findings/Outcomes
Purpose: To evaluate the
Non-experimental study
Bacterial strains were
The antibacterial properties of
antibacterial properties of
cultivated in MRS broth
the Lactobacillus strains
Lactobacillus strains on
using well diffusion assay,
tested were very variable.
common urogenital bacteria.
and 100 ul of Lactobacillus
Only L. plantarum showed
culture fluid were added to
inhibitory activity against
Level of Evidence: III
each well. The inoculated
GBS.
plates were incubated for 24
Quality of Evidence: B
hours at 37°C and the
diameter of the inhibition
zone was measured.
Strengths: Several actions evaluated, including hydrogen peroxide activity and tolerability of acidic environments (i.e., the GI
tract).
Limitations: Focused on urogenital pathogens, specifically patients who had clinical symptoms of UTI and positive urine
cultures.
Implications: Lactobacilli are commonly found in the human vagina and stool, and may have efficacy against urogenital
pathogens.
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Source: Reid, G., Charbonneau, D., Erb, J., Kochanowski, B., Beuerman, D., Poehner, R., & Bruce, A. W. (2003). Oral use of
lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: Randomized, placebo-controlled trial
in 64 healthy women. FEMS Immunology and Medical Microbiology, 35(2), 131-134. doi:S0928824402004650
Location: Canada
Purpose/Level/Quality
Design
Measurement
Findings/Outcomes
Purpose: To evaluate the
Randomized controlled trial. 64 women, ages 19-46, were The culture findings showed
effect or an oral regimen of
randomly allotted to receive
that lactobacilli oral therapy
two lactobacillus strains on
either a capsule contained
led to a significant (log 10)
vaginal flora.
two lactobacillus strains or a increase in vaginal
placebo. Two vaginal swabs
lactobacilli within 4 weeks (p
Level of Evidence: I
were collected at days 0, 7,
= 0.01), plus a 0.8 log 10
28, 60, and 90, and cultured
decrease in yeasts (p = 0.01)
Quality of Evidence: B
for total lactobacilli, yeast,
and coliforms (p = 0.001)
and coliforms using standard compared to the placebo.
diagnostic media and
biochemical tests.
Strengths: Demonstration that lactobacillus have effect with taken orally.
Limitations: Not specific to GBS.
Implications: Oral regimens of lactobacillus strains can impact vaginal flora.
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Source: Rönnqvist, P., Ström, H., Forsgren-Brusk, U., & Håkansson, E. G. (2005). Selection and characterization of a
lactobacillus plantarum strain promising as a urogenital probiotic. Microbial Ecology in Health & Disease, 17(2), 75-82.
doi:10.1080/08910600510037992
Location: Sweden
Purpose/Level/Quality
Design
Measurement
Findings/Outcomes
Purpose: To identify strains
Non-experimental study.
Lactobacillus strains (n =
Lactobacillus plantarum
of Lactobacillus that alter
511) were isolated from the
LB931 exerted a bactericidal
vaginal flora.
vaginas of healthy fertile
effect on 93% of all ITS (n =
women from the northern
311), furthermore the growth
Level of Evidence: III
part of Sweden.
of GBS was totally inhibited.
Quality of Evidence: B

Daily use of panty liners
impregnated with freezedried lactobacilli, and
adherence was measured as
the number of lactobacilli
transferred from the panty
liners to the urogenital area.

Strengths: Testing in age ranges that are not typically colonized with their own lactobacilli.
Limitations: Not all strains may survive freeze-drying process.
Implications: Lactobacilli has inhibitory action against urogenital bacteria.

Lactobacillus plantarum
LB931 could be isolated in
the perineum in all girls as
long as the panty liner was
used.
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Source: Ronnqvist, P. D., Forsgren-Brusk, U. B., & Grahn-Hakansson, E. E. (2006). Lactobacilli in the female genital tract in
relation to other genital microbes and vaginal pH. Acta Obstetricia Et Gynecologica Scandinavica, 85(6), 726-735.
doi:743725790
Location: Sweden
Purpose/Level/Quality
Design
Measurement
Findings/Outcomes
Purpose: To evaluate the
Randomized controlled trial. One hundred and ninety-one Women with high numbers of
effect of lactobacilli on
(191) subjects were divided
lactobacilli were less
vaginal pH.
into intervention and control prevalent with GBS than
groups. The LB931 group
women with low numbers (p
wore vapor-permeable panty = 0.036). High numbers of
Level of Evidence: I
liners impregnated with
lactobacilli may contribute to
Lactobacillus plantarum
a low vaginal pH and seem to
Quality of Evidence: A
LB931 24 hours a day for
have a negative influence on
four consecutive menstrual
GBS.
cycles. Microbiological
samples were taken and
vaginal pH was registered the
week preceding each
menstruation during the study
period.
Strengths: Alternative method of applying the Lactobacillus to the vagina.
Limitations: Other factors, such as sexual activity, that can be associated with GBS was not considered in the analysis.
Implications: Panty liners may be a viable option for application of Lactobacillus.
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Source: Ruiz, F. O., Gerbaldo, G., Garcia, M. J., Giordano, W., Pascual, L., & Barberis, I. L. (2012). Synergistic effect
between two bacteriocin-like inhibitory substances produced by lactobacilli strains with inhibitory activity for streptococcus
agalactiae. Current Microbiology, 64(4), 349-356. doi:10.1007/s00284-011-0077-0
Location: Argentina
Purpose/Level/Quality
Design
Measurement
Findings/Outcomes
Purpose: To evaluate the
Non-experimental study.
A total of 57 S. agalactiae
The 52 strains showed
effect of two strains of
strains were isolated from
different degree of
lactobacillus on GBS.
760 pregnant women at 35susceptibility, but all of them
37 weeks of gestation during were sensitive to L.
36 months. Inhibitory effects fermentum L23 and L.
Level of Evidence: III
of the bacteriocin-like
rhamnosus L60. It was found
inhibitory substance (BLIS)
that there is a synergistic
Quality of Evidence: A
was evaluated by well
effect between the strains of
diffusion test on agar plates,
lactobacillus when used
on S. agalactiae as well as
against a pathogen.
other pathogens.
Strengths: Sensitivity of pathogens to specific strain.
Limitations: In vitro work has limited applicability to in vivo use at this time.
Implications: The synergism aspect could support the use of multi-strain regimens, rather than just one strain.
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Source: Stray-Pedersen, B., Bergan, T., Hafstad, A., Normann, E., Grøgaard, J., & Vangdal, M. (1999). Vaginal disinfection
with chlorhexidine during childbirth. International Journal of Antimicrobial Agents, 12(3), 245-251. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/10461843
Location: Norway
Purpose/Level/Quality
Design
Measurement
Findings/Outcomes
Purpose: Determine whether Randomized controlled trial. Vaginal cultures were
When comparing the two
chlorhexidine vaginal
obtained, and then vaginal
douched groups, the infants of
douching reduced mother-todouching with aqueous 0.2% the chlorhexidine group had
child transmission of vaginal
chlorhexidine solution or
significantly less overall
microorganisms including
sterile isotonic saline was
neonatal morbidity of
GBS.
used every six hours until
infectious diseases than those
delivery. Cultures were
of the saline group (p =
routinely obtained from the
<0.05, 95% CI 0.00-0.06).
Level of Evidence: I
throat, nose, and ear
immediately after birth.
Quality of Evidence: B
Infants born to mothers with
vaginal GBS had additional
eye and throat cultures
obtained.
Strengths: Direct application of chlorhexidine.
Limitations: Addressing GBS transmission retrospectively.
Implications: Use of chlorhexidine could provide a reduction in neonatal morbidity.
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Source: Zarate, G., & Nader-Macias, M. (2006). Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital
pathogens to vaginal epithelial cells. Letters in Applied Microbiology, 43(2), 174-180. doi:LAM1934
Location: Argentina
Purpose/Level/Quality
Design
Measurement
Findings/Outcomes
Purpose: To evaluate the
Non-experimental study.
The inhibitory effect of
Only L. acidophilus CRL
ability of four vaginal
lactobacilli was measured by 1259 and L. paracasei CRL
lactobacillus strains to block
blockage by exclusion,
1289 inhibited the attachment
the adherence of urogenital
competition, and
of GBS to VEC by exclusion
pathogens to vaginal epithelial
displacement. Bacterial
and competition, respectively.
cells.
adhesion to VEC was
quantified by microscopy
(x1000) after Gram’s stain.
Level of Evidence: III
Quality of Evidence: B
Strengths: Identification of type of inhibition.
Limitations: In vitro results may not have applicability for in vivo use.
Implications: Lactobacillus strains have efficacy against urogenital pathogens.
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Chapter IV: Discussion, Implications, and Conclusion
The research question posed was: What are effective interventions of reducing GBS
colonization and related intrapartum antibiotic administration? Articles (n=22) on nonantibiotic methods that could potentially reduce GBS colonization were appraised using the
Johns Hopkins Research Evidence Appraisal Tool (Dearholt & Dang, 2012). The findings
were then synthesized to evaluate the strength of research about the alternative methods,
evaluate trends and gaps in the literature, and identify further research opportunities. Germ
theory was applied as the theoretical framework.
Trends
The idea that there should be non-antibiotic methods to prevent EOGBSD in the
neonate has always been a matter of discussion. However, the methods being studied have
shifted according to the research interests of the time. Chlorhexidine was studied primarily
in the 1990’s, but the Cochrane Review published in 2002 (updated in 2004 and 2014)
discussed the lack of compelling results, seeming to signal the end of the focus on
chlorhexidine as a method of interest. In the 2000’s the increasing popularity and interest in
probiotics brought forth a considerable amount of research, evaluating the potential of
probiotics effect on pathogens with particular interest in vaginal flora, which could then
potentially affect GBS. The articles in this review are dated as recently as 2014, so it
remains to be seen if probiotics will evolve from hypothesis into effective intervention, or if
they will simply fade away from lack of compelling results.
From a consumer perspective the trends are being driven by demands for alternatives
to antibiotics, in light of the concern about antibiotic resistance and “superbugs”, as well as
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the idea that antibiotics may not truly be an effective method of prevention of neonatal
EOGBSD. Anecdotal evidence suggests that the use of alternative methods, particularly
preventative probiotics, or regimens using garlic or Melaleuca alternifolia (tea tree oil) to
treat known GBS colonization, are increasing. The rates of women who choose not to be
tested at all are increasing as well, as they cite lack of treatment availability (a birth provider
not authorized to administer antibiotics), concern about long-term effects of antibiotic use,
or concern that antibiotics are not effective. Further research on the human microbiome
gives further credence to the idea that altering the flora of a human can have long-term
effects on their health.
Gaps
Current studies of probiotics effect may lack generalizability to in vivo use, as there
are many potential variables that its impossible to draw conclusions from research that is
conducted entirely in vitro. The specifics that need to be addressed include which strains are
the most beneficial, determination of the mount of probiotic intake required to survive GI
tract and be found in vagina (Hanson, VandeVusse, Duster, Warrack, & Safdar, 2012) as
well as whether or not probiotics need to be taken continually for best effect or if ‘one-time
dose’ methods are effective.
Benzalkonium chloride and garlic are currently not supported in the research, each
with so few studies that make it impossible to draw any reasonable conclusions.
Considerable research about preparations, route of administration, and in vivo effect would
be required before benzalkonium chloride or garlic could be considered reasonable
alternatives.
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The standard method of identifying GBS colonization is a culture carried out
between 35 and 36 weeks, and the results are usually available within one week. However,
Young, et al. (2011) found that the 35-36 week culture test only identified 69% of the
women who actually had GBS during labor (as cited in Dekker, 2013).
Young, et al. (2011) found that 84% of those who tested positive at 35-36 weeks
were still positive in labor, which suggests that 16% of that group were receiving
unnecessary antibiotics. If this is broadened to the general population it would suggest that
there is a percentage of women who are being treated with antibiotics but are GBS negative,
but even more concerning are the women who were GBS negative at testing but are
colonized with GBS at delivery and do not receive antibiotic prophylaxis. In women
screened at 35-37 weeks, 91% of those who tested negative were still negative at labor
(Young, et al., 2011) which suggests that 9% of women who became positive in that time
were not receiving antibiotics.
Rapid tests that can provide results in labor are being developed and introduced to
the market, however despite their use in Europe they have not become widely used in the
United States. El Helali et al. (2012) followed a French hospital as it switched from prenatal
testing to in-labor testing, and increased its rate of GBS identification, had fewer cases of
early GBS infections in newborns, with the same financial cost. Its unclear why rapid tests
are not being utilized in the United States, but they appear to have a potential to increase
identification and lower the rates of GBS infections in infants. There is speculation that the
time it takes to test and cost-effectiveness of this testing are contributing factors to its low
utilization (Dekker, 2013).
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Future Research
Use of probiotics in pregnant women has generally been regarded as safe, but there
have been no studies published that specifically look at the effect of probiotic use on GBS
colonization in pregnancy. Stanford University has a study currently ongoing, but the results
of that study are not due to be published until November 2018 (ClinicalTrials.gov, 2016).
Further research is needed on in vivo use of probiotics to reduce GBS colonization in
pregnant women, as well as more strain-specific studies to determine what combination of
strains has the most effect. Determining whether oral or vaginal probiotics are the most
effective, and whether or not the regimen would be well-tolerated are important research
considerations, as is the amount of probiotics that are required in order to survive the GI
tract and alter vaginal flora.
Water birth had initially brought forth concerns about increased rates of GBS
colonization. However, Jah (2014) specifically mentioned water birth as a method of
reducing GBS colonization, citing the findings of Zanetti-Daellenbach, et al. (2006) that
although the water had higher levels of GBS colonization, infants born in the water had
decreased rates of GBS colonization, theorized as a “wash out effect”. A later study by
Zanetti-Daellenbach, et al. (2007) had a larger sample size and found that the outcomes of
GBS colonization and EOGBSD of the neonate were comparable between the neonates born
in the water versus those born out of the water. Further research would be warranted to
determine if neonates born in the water to GBS positive mothers have lower rates of GBS
colonization than infants born out of the water to GBS positive mothers.
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Implications
While it would appear that antibiotics are the best solution at the current time, there
is a paucity of research for any alternative methods that will be required soon if bacterial
resistance continues its projected course. The fear of antibiotic resistance is well-founded,
and it gives further urgency to the study of non-antibiotic methods, particularly methods that
do not disrupt the existing microbiome.
Application and Integration of Theoretical Framework
No study of a microorganism’s role in pathophysiology would be complete without
the inclusion of germ theory. Once considered revolutionary, germ theory has become basic
science that is part of the foundation of biomedicine. The challenge is that colonization with
GBS is a normal part of vaginal flora, and rarely problematic in non-pregnant women.
However benign it may be in the adult woman, it becomes a potentially life-threatening
cause of infection if transmitted to the neonate. Unlike a surgical infection where new
bacteria are introduced from an outside source, such as contaminated hands as a result of
poor hand washing techniques, GBS is often pre-existing as a part of normal flora and only
offers risk after reaching a certain threshold in specific situations. Concerns about the
microbiome aside, the option of eliminating all vaginal flora with antibiotics will not remain
an option forever in the era of antibiotic resistance. The ideal solution for preventing GBS
colonization would be highly effective at eliminating GBS colonization in the vagina,
minimally-invasive (i.e., not requiring intravenous access), low cost, be accessible without a
prescription, readily available, easy to use or apply, and not disrupt the existing flora making
up the host’s microbiome.
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Conclusion
The major finding of this review emphasizes that while non-antibiotic methods of
reducing the colony count have limited support in the literature, it is almost without
exception due to a lack of research, rather than the research not supporting the methods. The
idea of garlic or probiotics as the answer to such a formidable foe as GBS seems prosaic,
however it is not unlike the idea that hand washing can prevent death from infection. When
Joseph Lister was practicing medicine, many refused to believe that tiny organisms could
exist and, even when proven, most struggled with the concept that organisms existed in
states of both health and disease (Jessney, 2012). It would be foolish to discount simpler
methods for their simplicity, and the looming deadline of antibiotic resistance requires
persistence and expediency. Researchers must aggressively focus on non-antibiotic methods
of reducing neonatal EOGBSD to find reasonable alternatives, before once again babies are
lost to a preventable disease.
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